This study aimed to evaluate the effect of chronic treatment with chaetomellic acid A (CAA) on oxidative stress and renal function in amodel of renalmass reduction. Methods.MaleWistar ratswere subjected to 5/6 nephrectomy (RMR) or sham-operated (SO). One week after surgery, rats have been divided into four experimental groups: RMR: RMR rats without treatment (n = 14); RMR + CAA: RMR rats treated with CAA (n = 13); SO: SO rats without treatment (n = 13); and SO + CAA: SO rats treated with CAA (n = 13). CAA was intraperitoneally administered in a dose of 0.23 μg/Kg three times a week for six months. Results. RMR was accompanied by a significant reduction in catalase and glutathione reductase (GR) activity (p < 0.05) and a decrease in reduced ...
Arachidonic acid (ARA), an omega-6 (ω-6) polyunsaturated fatty acid (PUFA), is involved in the devel...
The aim of this study was to evaluate possible changes in renal hemodynamic and urodynamic parameter...
The present study aimed to characterize the chlorogenic acid (ChlA) capacity to reverse the toxic ef...
This study aimed to evaluate the effect of chronic treatment with chaetomellic acid A (CAA) on oxida...
Chaetomellic acid A (CA) is a potent and highly specific inhibitor of Ras farnesyl-protein transfer...
The main research goal in patients with chronic kidney disease (CKD) is the development of new thera...
Chaetomellic acid (CA) is a potent and highly specific inhibitor of ras farnesyl-protein transferas...
The high prevalence of end-stage renal disease emphasizes the failure to provide therapies to effect...
To study the effect of chronic treatment with chaethomellic acid (CA), a highly specific inhibitor ...
To study the effect of chronic treatment with chaethomellic acid (CA), a highly specific inhibitor ...
Objective: The high prevalence of chronic kidney disease underscores the failure to provide therapie...
Uric acid has promoted renal fibrosis and inflammation in experimental studies, but some studies hav...
The high prevalence of chronic kidney disease underscores the failure to provide therapies to effect...
BackgroundOxidative stress and inflammation promote the development and progression of chronic kidne...
Uric acid has promoted renal fibrosis and inflammation in experimental studies, but some studies hav...
Arachidonic acid (ARA), an omega-6 (ω-6) polyunsaturated fatty acid (PUFA), is involved in the devel...
The aim of this study was to evaluate possible changes in renal hemodynamic and urodynamic parameter...
The present study aimed to characterize the chlorogenic acid (ChlA) capacity to reverse the toxic ef...
This study aimed to evaluate the effect of chronic treatment with chaetomellic acid A (CAA) on oxida...
Chaetomellic acid A (CA) is a potent and highly specific inhibitor of Ras farnesyl-protein transfer...
The main research goal in patients with chronic kidney disease (CKD) is the development of new thera...
Chaetomellic acid (CA) is a potent and highly specific inhibitor of ras farnesyl-protein transferas...
The high prevalence of end-stage renal disease emphasizes the failure to provide therapies to effect...
To study the effect of chronic treatment with chaethomellic acid (CA), a highly specific inhibitor ...
To study the effect of chronic treatment with chaethomellic acid (CA), a highly specific inhibitor ...
Objective: The high prevalence of chronic kidney disease underscores the failure to provide therapie...
Uric acid has promoted renal fibrosis and inflammation in experimental studies, but some studies hav...
The high prevalence of chronic kidney disease underscores the failure to provide therapies to effect...
BackgroundOxidative stress and inflammation promote the development and progression of chronic kidne...
Uric acid has promoted renal fibrosis and inflammation in experimental studies, but some studies hav...
Arachidonic acid (ARA), an omega-6 (ω-6) polyunsaturated fatty acid (PUFA), is involved in the devel...
The aim of this study was to evaluate possible changes in renal hemodynamic and urodynamic parameter...
The present study aimed to characterize the chlorogenic acid (ChlA) capacity to reverse the toxic ef...